← All companies

TerraVest

TVK.TOTorontoCADIndustrial manufacturingReviewed Nov 4, 2026

Acquisition and restructuring compounder

8 of 11 research checks complete. Still to complete: Security and evidence base; Opportunities and funded scenarios; Variant view and catalysts · TTM to June 2026; June bank debt/shares; March claim estimates; July SPV purchase

Buy industrial businesses, improve their cash earnings and redeploy within debt capacity.

  • Deal cost and NOPAT after restructuring, including all claims
  • Cash generation, debt capacity and refinancing headroom
  • Replacement demand versus structural decline and cyclical orders
Inspect live quotes, sensitivity grid & cash-flow bridge

Scenario assumptions

Acquisition and restructuring compounder · TTM to June 2026; June bank debt/shares; March claim estimates; July SPV purchase

DriverDownsideBaseUpside
Exit EV / normalized cash NOPAT13.00×17.00×17.00×
Net debt / existing-business EBITDA2.40×2.40×2.40×
Organic revenue growth
Years 1–5: 0.0%
Years 1–5: 0.0%
Years 1–5: 0.0%
NOPAT margin on organic revenue
Year 1: 4.8%
Year 2: 6.0%
Years 3–5: 7.2%
Years 1–5: 9.6%
Years 1–5: 9.6%
EBITDA margin on organic revenue (debt capacity)
Year 1: 9.0%
Year 2: 11.3%
Years 3–5: 13.5%
Years 1–5: 18.0%
Years 1–5: 18.0%
Price paid per unit of acquired revenue
Years 1–5: 0.88×
Years 1–5: 0.88×
Years 1–5: 0.88×
Recovered NOPAT margin of acquired businesses
Year 1: 3.7%
Year 2: 4.6%
Years 3–5: 5.5%
Years 1–5: 11.9%
Years 1–5: 18.9%
  • Downside case. Borrowing capacity falls with earnings, stopping deals while debt exceeds the ceiling. The original 13× EV/NOPAT multiple prices the reduced earning power. Revenue and cash margins are now explicit yearly paths with matched purchased sales; current KBK missing months and all-in costs replace the old half-year shortcut.
  • Base case. Pay interest, dividends and identified vendor/earnout claims before deploying capacity. Existing-business net debt capacity remains 2.4× EBITDA; new deals are small (the deployment budget cannot buy another Entrans) and are priced at the sellers’ trailing earnings on Highland and KBK’s issuer multiples (7.40× mature NOPAT), reaching that level over the three-year ramp with no restructuring uplift. Value terminal cash NOPAT at the original 17× EV multiple. Revenue and cash margins are now explicit yearly paths with matched purchased sales; current KBK missing months and all-in costs replace the old half-year shortcut.
  • Upside case. Keep zero organic growth, the three-year ramp, the 2.4× existing-business debt ceiling and the 17× exit. This isolates better purchase economics; it adds no leverage, free growth or rerating. Revenue and cash margins are now explicit yearly paths with matched purchased sales; current KBK missing months and all-in costs replace the old half-year shortcut.

Research notebook

Reviewed Nov 4, 2026

8 of 11 research checks complete. Still to complete: Security and evidence base; Opportunities and funded scenarios; Variant view and catalysts
Business model

TerraVest buys small and mid-sized North American manufacturers of steel and fibreglass tanks, pressure vessels, tank trailers, heating appliances and Western Canadian energy equipment and services. It then restructures purchasing, plants and incentives and leaves the subsidiaries to run with a very small head office.

Money is C$ millions unless stated. Fiscal years end 30 September. TTM means the twelve months to 30 June 2026 (FY2025 + 9M FY2026 − 9M FY2025).

Value-creation mechanism

The mechanism is acquire cheaply, restructure, then redeploy the cash within a leverage ceiling. The levers are concrete and mostly on the cost side. Steel is roughly half of a tank's cost of goods, so mill-direct purchasing at group volume, consolidating nearby plants, sharing welders and a profit-not-revenue mindset raise margins on the same price. The second step, buying, matters more than it used to. The deals are now far larger (Entrans cost C$779.6m in March 2025, against C$240m for all eighteen deals from 2014 to 2022), so the purchase multiple and the cycle at purchase now drive more of the value than plant-level restructuring does. Re-underwriting today (research/07-assumption-register.md, 3 November 2026) found the FY2024–TTM cohort earning 16.6× its capital, against 9.9× at the sellers' trailing earnings. That gap is the trailer downturn at Entrans, not a failed restructuring yet. The value step to watch is therefore no longer only whether TerraVest can restructure, but whether it can buy at cycle-normal earnings when the deals are large enough to matter.

Business-model profile

Comparable firms are chosen by these traits, not by the industry label.

Growth vehicle: Acquisitions. Revenue rose from 307.5 in FY2021 to 1,371.2 in FY2025. Of the 1,071.1 invested for growth in FY2024–FY2025, net acquisitions took 999.5 (93%); organic working capital and growth capex took the remaining 7%. Acquisition cash was 34.6% of revenue over FY2023–FY2025, Entrans dominating FY2025. The model funds acquisitions from cash and borrowing capacity each year, with a quiet year where debt is above the limit.

Capital intensity: 5.3% of sales, capital-intensive. Capital spending, including the rental fleet, is about 5.3% of revenue: plants for steel and fibreglass tanks, pressure vessels and trailers, and rental equipment. Tangible capital including leases was 892.3 at September 2025, mostly working capital and plant. The capital that drives growth is acquisition cash (34.6% of revenue over FY2023–FY2025).

Comparables. A comparable firm buys small and mid-sized manufacturers in fragmented industrial niches, funds deals from cash flow and debt capacity, improves purchasing and plants after purchase, and grows organically only with its end markets. Its revenue follows energy, agriculture and housing cycles. Not the label: "Industrial machinery" suggests an organic manufacturer; TerraVest grows by acquisition and is constrained by debt capacity.

Declared in valuation/model.json (businessProfile). npm run check measures deal and capital intensity from the reported facts, and the outside view grades the forecast only against firms that share them.

Economic snapshot

Definitions. Returns use TTM June 2026 earnings against the 30 September 2025 balance sheet, the latest audited one (terravest-fy2025-fs). The mismatch matters a little: KBK (C$125m, January 2026) is half in TTM earnings but not in September capital. Earnings are normalized cash NOPAT on the baseline definition: adjusted EBITDA less issuer maintenance capex (in place of depreciation), lease principal and lease interest, taxed at 25%. Before minorities this is 178.2 (preMinorityNopat, valuation/calculations.json); after the GES minorities it is 166.0.

Capital at 30 Sep 2025C$m
PP&E (incl. rental fleet)302.8
Right-of-use assets223.0
Operating working capital excl. cash (receivables 210.4 + inventory 351.6 + other 37.6 − payables 172.5 − customer deposits 58.2 − tax 2.6)366.4
Tangible operating capital, leases capitalized892.3
Acquired intangibles 390.1 + goodwill 461.1851.1
Bank and term debt 754.0; lease liabilities 237.0; cash 13.9 (no excess cash)
Investments at fair value (non-operating, credited separately) 63.1
Return (after tax, TTM)NumeratorCapitalReturn
ROTC: leases capitalized (NOPAT before minorities + after-tax lease interest 13.2)191.5892.321.5%
ROCE: leases expensed, tangible (PP&E + working capital)178.2669.326.6%
ROCE including acquired goodwill and intangibles178.21,520.411.7%
Same, adding the H1 FY2026 deal capital (132.9)178.21,653.310.8%

Tangible returns have since risen; returns including purchase premiums have fallen to about 11%, because FY2025 bought C$960m of businesses, mostly goodwill and intangibles. The operating businesses are good on their own tangible capital. The question is what TerraVest earns on the price it pays for them.

Margins and turnsFY2021FY2022FY2023FY2024FY2025TTM Jun-26
Revenue307.5576.7678.4911.81,371.21,731.2
Gross margin26.2%21.6%24.5%28.9%27.8%25.2% (9M)
Adjusted EBITDA margin21.4%15.0%17.9%20.8%19.3%18.0%
Cash NOPAT / revenue11.3%10.9%9.6%

FY2021 EBITDA includes C$18.1m of COVID subsidies; without them the margin was 15.5% (covidSubsidiesFY2021). Inventory was 119 days of cost of sales at FY2024 and 130 days at FY2025; the year-end figure overstates the run rate because it holds all of Entrans's inventory against 6.5 months of its costs. Receivables were 51 and 56 days. TerraVest deliberately carries steel ahead of its peak quarters (Q1 and Q4), so a 120–140 day inventory is the business model, not slippage. The incremental EBITDA margin from FY2023 to TTM was 18.1% (190.6 on 1,052.8 of added sales), almost all acquired.

Normalization. TTM maintenance capex (41.2) now roughly equals FY2025 PP&E depreciation (41.3), so the baseline charges about 100% of depreciation. Q3 FY2026 maintenance rose to 14.4 from 4.6 a year earlier, mainly in Service; that is used rather than smoothed away. Minorities (12.2 TTM) are mostly the 33% outside stake in GES (Service). The Entrans earnout reversal (48.3) and bargain-purchase gains (5.3 in 9M FY2026) are excluded from earning power.

Economic segmentation

Reported segments mix economics. Entrans tank trailers sit in Compressed Gas Equipment next to propane storage tanks. Data-centre fuel tanks are built in HVAC and Containment but partly in other segments' plants. Water-management services in Service are 67% owned. Segment adjusted EBITDA (pre-lease, before corporate) for 9M FY2026 was HVAC 118.9, Compressed Gas 58.2, Processing 7.6 and Service 52.8 (Q3 MD&A pp.7–10). Adding an estimated Q4 FY2025 (FY2025 segment net income + D&A + financing less 9M FY2025 adjusted EBITDA) gives an approximate TTM of HVAC 143, Compressed Gas 101, Processing 11 and Service 69. That totals about 325, against a group TTM of 312 after corporate costs.

Re-cut by how profit is made (estimates; the HVAC heating/tank split and the Compressed Gas trailer/tank split are not disclosed):

Economic unitApprox. TTM EBITDAShareDemand driverCharacter
Stationary tanks and pressure vessels: propane/NH3 bulk and residential tanks, refined-fuel and data-centre generator tanks (Highland, KBK, Simplex, Granby tanks)130–15540–48%Replacement of an installed base; c-store and fuel storage rules; data-centre buildReplacement core plus a project boom
Transport equipment: tank trailers, bobtails (Entrans, LBT, Tankcon, Advance, MTC, SPV)60–7518–23%Fleet replacement by chemical, fuel, food-grade and LPG carriersCyclical; at a trough
Heating appliances: cast-iron boilers and furnaces (ECR, Granby)30–4510–14%Replacement in older North-eastern homesSlowly declining, cash-generative
Western Canadian energy: water management, flowback, rentals, processing equipment (GES/Fraction, Colter, NWP)about 80about 25%Western Canadian drilling and completion activityCyclical; one-third owned by minorities

The trailer unit is why the TTM is below purchase-time earnings. Compressed Gas's adjusted margin fell from 16.5% in FY2024 to 9.6% for 9M FY2026 and 8.7% in Q3. HVAC's margin (25.7% for 9M FY2026, against 24.5% a year earlier and 25.5% in FY2024) did not jump. The data-centre boom is therefore volume at normal margins, not a price windfall. HVAC base-portfolio sales rose 66 in 9M FY2026, roughly 22 of annualized EBITDA, or about 7% of group EBITDA. If that project volume fades, it is a cyclical give-back of that size, not a margin collapse.

Unit economics

The unit through which TerraVest adds value is the acquired company. Three units, in absolute money:

Gross profit per vessel goes from about C$70k to C$125k, and gross margin from 20% to 34%. Almost all of the gain is buying power and labour productivity on an unchanged product.

Highland Tank (November 2023), a good recent deal. Price 106.5 (including 6.9 in shares; highlandConsideration), at about 4.0× the seller's TTM EBITDA of about 26.6 (issuer release). On the price paid that is a 19.7% after-tax yield (5.1×), against a 9–10% cost of capital. Highland then became the platform for the data-centre tank volume and for Simplex (April 2025, EV about US$28m).

Entrans (March 2025), the large deal at the wrong point in the cycle.

EntransAt purchaseTTM June 2026 (estimate)
Capital: cash consideration (earnout not paid)779.6779.6
EBITDA after rentabout 111 (7.0× issuer multiple)about 56 (pre-rent IFRS, acquired trailer businesses incl. LBT and Tankcon)
NOPAT (group conversion 0.64 after rent; 0.53 pre-rent)about 71about 30
After-tax yield on capital9.1%about 3.8%

The up-to-US$46m earnout depended on Entrans's first twelve months. It was reversed as a C$48.3m gain in Q1 FY2026 (entransEarnoutGain9mFY2026), so the seller's own targets were missed. Compressed Gas Q3 FY2026 EBITDA was 17.3 against 29.7 a year earlier, as US tank-trailer demand fell (Q3 MD&A p.8). A unit earning 3.8% on its price destroys value at a 9–10% hurdle until it recovers. On a two-to-three-year view, Entrans is genuinely different from the bolt-on pattern. It was bought at near-peak trailer earnings, already had scale purchasing, and its shortfall is volume, not cost. Its recovery is upside to existing earnings, not evidence about future bolt-on prices. Entrans already had scale purchasing as the industry leader, so the 15% steel saving on a mom-and-pop does not transfer automatically.

Failures, with reasons.

  • Iowa Steel Fabricators (bought 2019 for about 11.6): closed in FY2026 (Q3 MD&A p.8).
  • The biogas activity in Processing: terminated early in FY2026 after low-margin jobs.

These exits are evidence that the team cuts losers rather than funding them. They also show the lever works only where TerraVest's purchasing scale is large relative to the supplier.

Independent checks

  1. Peers' audited results. Wabash's Q3 2026 release (wabash-q3-2026) reports an adjusted operating loss on weak trailer demand, and ACT reports depressed trailer orders (act-trailers-october-2026). The Entrans shortfall is industry-wide, so it does not by itself show an integration failure. A failed integration would show as Compressed Gas margins below peers when the cycle turns. That cannot be tested yet.
  2. Adverse allocation. Charge all corporate costs (about 12.7 TTM EBITDA, roughly 6.8 after tax) to the acquired cohort, and value KBK at only its TTM months. The FY2024–TTM achieved multiple rises from 16.6× to about 18.8× (964 / 51.4). The conclusion survives: at today's trough earnings, recent deals do not cover the cost of capital. Only a recovery in trailer earnings makes the cohort economic.

This study's evidence says the recent cohort is not yet earning them. The observation that would settle it is Compressed Gas segment EBITDA in FY2027 relative to its FY2025 level (98.7 IFRS basis). A return above about 80 would point to the base case; staying near 60–70 would point to the downside.

History, market & cycle

The 2024 case rested on the management team's record of buying and improving industrial businesses. The source valuation starts with FY2023 economics, adds Highland and LV after restructuring, and estimates further capital deployment through FY2026. It is a forecast vintage, not an FY2026 result.

The portfolio has since changed. Revenue grew from 678.4 (FY2023) to a TTM 1,731.2 at June 2026, and adjusted EBITDA from 121.6 to 312.2. Base-portfolio sales growth (issuer definition, excluding the year's acquisitions) was about +1% in FY2023, +4% in FY2024, +1% in FY2025 and +8% in 9M FY2026. The rest of the growth was bought.

Demand drivers and cycle

Who pays and who decides.

  • Propane and NH3 tanks: the payers are propane retailers and fertilizer distributors, who own the tanks at customers' sites. They decide on delivery time and price.
  • Data-centre generator fuel tanks: the developer pays, and the EPC or genset supplier specifies them.
  • Tank trailers: carriers of fuel, chemicals, food-grade and cryogenic products pay and decide, mainly on fleet age and freight economics.
  • Western Canadian services: exploration and production companies pay and decide, against their drilling and completion budgets.

Demand split (judgment, by economic unit from 01-business.md).

  • Growth and regulation-driven demand comes from data-centre backup fuel storage, c-store and agricultural fiberglass tanks (KBK), and fuel-system rules.
  • Discretionary or cyclical demand comes from trailer fleet additions and Western Canadian activity.

Cycle measured, not described.

  • The current cycle is in trailers. Compressed Gas adjusted EBITDA was 17.3 in Q3 FY2026 against 29.7 a year earlier, on base-portfolio sales down 13% (Q3 MD&A pp.7–8). ACT's September 2026 trailer orders and Wabash's Q3 2026 results show an industry-wide downturn in new trailer demand, with tariff pull-forward clouding the timing (act-trailers-october-2026, wabash-q3-2026).
  • The offset is data centres. HVAC base-portfolio sales rose 61% in Q3 and 23% for nine months, and management expects the strength to continue near term (Q3 MD&A pp.5, 7).
  • Western Canadian services grew 11–17% excluding Colter in 9M FY2026.
  • The group's total base-portfolio growth of +8% therefore nets a trailer contraction against two booms.

Misperception and its test. The market's view since June 2026 appears to be that the deal engine is impaired: by governance (the AMF allegations, 03-management.md) and by an expensive cyclical deal (Entrans). The series that tests the second belief is Compressed Gas segment EBITDA through FY2027, read against ACT and FTR tank-trailer orders. A recovery to the FY2025 run rate (about 99 on an IFRS basis) with orders recovering would show Entrans was bought at a cyclical high rather than overpaid structurally. No series yet tests whether data-centre volume is durable. HVAC base-portfolio sales growth is the observation to watch.

Competition

Competition happens in three different places:

The number of competitors is falling as family owners retire. TerraVest buys many of them (Advance, LBT, Tankcon, SPV and Jet Peinture in two years), which is both the acquisition runway and the consolidation trend.

The advantage in one sentence: the lowest steel and labour cost per vessel among regional fabricators, from group-scale purchasing and shared plants, plus a buyer of last resort for retiring owners who want continuity rather than a top price. It is durable where TerraVest's volume is large relative to its suppliers (steel plate, valves) and weak where a single supplier controls a component (ECR's heat exchangers).

The competitor who could hurt it: private equity for larger deals, and an integrated trailer maker cutting price in a downturn. The Entrans multiple (7.0× after-rent EBITDA, about 9.9× NOPAT) shows TerraVest now pays closer to auction prices when it competes for scale assets.

Counterparty incentives

  • Sellers (founders and families). They want continuity of name, staff and location and a fair, certain price. The deal releases quote sellers wanting TerraVest to "grow the legacy" (terravest-deal-releases). TerraVest offers decentralization and keeps the brands. The sellers' outside option is private equity, which pays more but usually restructures and resells. The arrangement would change if TerraVest stopped honouring autonomy or if a governance scandal made it a less trusted buyer. The June 2026 allegations put that reputation at risk. SPV's owner still sold in July 2026, a month after they became public; B&R and Jet Peinture closed days before. One deal is too few to say the deal flow is unaffected.
  • Earnout sellers. Entrans's sellers had up to US$46m tied to twelve-month results, and the target was missed. An earnout transfers cyclical risk back to the seller only up to its size. Here it covered about 8% of the price.
  • Steel suppliers. Mills want volume and steady offtake. TerraVest concentrates purchasing to win discounts, so its dependence runs both ways. Where its share of a supplier's sales is small (ECR's foundry), the lever fails.
  • Customers: propane retailers, carriers and data-centre EPCs. Large propane retailers have buying power, but they value delivery time and local service. The data-centre EPCs are concentrated and project-based: a concentrated relationship that is currently a source of volume, and could leave.
  • Lenders. The syndicate holds a C$815m revolver plus term loans of 100 (March 2027) and 46 (March 2028) (Q3 MD&A pp.12–13). They want covenant compliance, and their leverage tolerance sets the deployment ceiling. TerraVest was in compliance in June 2026.
  • Minority partners in GES. About a third of the water-management unit's earnings go to them (minorities 12.2 TTM). Deals made through GES (LV, Aureus, Colter) share their returns.
  • Regulators. The Quebec AMF's investigation concerns the Executive Chairman's personal conduct, not the company's accounts (amf-allegation-reports-2026). The company says the AMF had not contacted it. The regulator wants deterrence. A charge would bear on board composition and on the company's reputation with sellers, not directly on cash generation.
Management & incentives

Gilbert sources and negotiates deals, Haw leads diligence and the operating changes, and Pellerin is involved throughout; subsidiary presidents supply operating knowledge. An investment in TerraVest is largely a bet on how these few people allocate free cash. The deals are now far larger. And in June 2026 the Executive Chairman became the subject of a securities-regulator investigation.

Evidence limits: the 2026 management information circular was not retrieved. Current holdings come from an aggregator transcription of filings (insider-holdings-aggregator-2026). Both are labeled.

Ownership and incentives

PersonRoleSharesOptionsCash payOpen-market recordBackground
Charles PellerinExecutive Chairman since 2014 (CEO 2015–17)3,356,500 (15.5%), Feb 2026; 3.5m in Jan 2024350k (Jan 2024)about C$0.2m (2024 report); aggregators show about C$0.44mBuyer: about C$9.8m net cash input, including 53k at C$16 (Jan 2021) and 10k at C$23 (Jul 2022)Partner of a Quebec accounting firm; co-owned Granby before TerraVest bought it; Clarke director
Dustin HawCEO since 2017; director since 2014175,889 (0.8%), Jan 2026500k (Jan 2024), likely most of the 2022 grantaveraged C$0.81m in 2021–23Small buyer at C$7–9 (2016–17)PhD physics, CFA; ex-Clarke VP
Mitch GilbertCIO since 2013117k (Jan 2024)333k (Jan 2024)about C$0.42mSeller: 147k at C$16 (May 2020), 17k at C$27 (2023)14 years in bank M&A
Mitch DeBelserPresident, Compressed Gas405k (Jan 2024)—about C$0.58m—Came with NWP (2014)
Pierre FournierPresident, HVAC79k (Jan 2024)—about C$0.5mSmall sellerGranby since 2006
Guillaume CloutierCFO, joined 2025n/an/an/an/aEx-CFO of an aerospace company
Directors Cook, Laniuk, Rossi, MacBeanBoardLaniuk 2.1m (2024), others small—C$44–54k each (2024)Laniuk and MacBean sellersCook chairs audit and sits on Clarke's board

Options outstanding at 30 June 2026: 616,500 from the February 2022 grant (strikes C$24.49–34.49) and 133,333 granted in February 2026 at C$142.61. That is 3.5% of shares (Q3 MD&A p.13). At C$107.85 the 2022 tranche is worth about C$49m of intrinsic value; the 2026 tranche is out of the money.

Whose interests dominate. At 10% a year for ten years the share price goes from C$107.85 to about C$280. Pellerin's stake would gain about C$577m against cash pay under C$0.5m a year. Haw's shares and (if he still holds about 500k of the 2022 options) options would gain about C$115m against roughly C$1m a year of pay. Share ownership, not salary, drives both. Pellerin's stake is more than ten times Haw's, which makes the chairman's position, and its possible sale, the more important variable.

The board "does not establish quantitative return on capital criteria for management" (Q3 MD&A p.13). There is no return-weighted metric to back out; alignment rests on ownership.

Track record and references

The peak was C$175.20 (yahoo-tvk-trading-2026-11).

Per-share earning power. Cash NOPAT per share (baseline definition) was C$5.28 in FY2024 (102.996 / 19.50m shares) and C$6.88 in FY2025 (149.300 / 21.69m). It was about C$7.75 for the TTM to June 2026 (166.0 / 21.43m). That is +47% per share in under two years, while the share count rose 9.9% from September 2024 to June 2026. Per-share value has grown even after equity issuance.

Including acquired goodwill and intangibles it is now about 11%, because recent deals are larger and priced nearer market multiples.

Decisions that failed or have not yet worked.

  • Iowa Steel (2019): closed in FY2026.
  • Biogas jobs: ended.
  • Entrans (2025, 80% of recent deal capital): earns about half its purchase EBITDA and missed its earnout.

It judged the bench shallow and middle management weaker (pp.28–29). No new references were collected for this study (no fieldwork claimed). Since then, the long-serving CFO has been replaced (2025) and the Executive Chairman is under investigation. Bench depth matters more than it did.

What trades reveal. In May and June 2025, near the share-price peak, 266,500 options were exercised cashlessly and 100,000 options from the January 2020 grant were settled for C$15.7m cash at C$170.05 (FY2025 FS note 19.2). The holders are not named in the statements. The company issued 2.0m shares at C$160.30 the same month. Executives monetized near the high, and the company sold stock near the high. Both are price-aware, the second in shareholders' favor.

Capital allocation principles

  1. Fund strategies, not projects. Met. Deals build platforms: Highland, then Simplex; Entrans, then LBT, Tankcon and SPV; GES, then LV, Aureus and Colter. Each platform's buying and plant network makes the next bolt-on cheaper to restructure.
  2. No tolerance for bad growth. Met at the unit level (closures and disposals above). Not yet testable for Entrans, which is cyclical rather than proven bad.

Governing objective. The MD&A states the aim of maximizing returns to shareholders through opportunistic acquisitions. Behaviour (per-share earning power, issuing dear and buying cheaper, closures) is consistent with long-term value per share. The Entrans scale, and the leverage taken to fund it, show a higher risk appetite than the 2014–2022 record.

Integrity and governance

The AMF investigation. On 5 June 2026, Le Journal de Montréal reported that Quebec's securities regulator obtained warrants to search Executive Chairman Charles Pellerin's home and other locations (11 and 13 February 2026). The AMF suspects he passed non-public information about the Entrans acquisition, which he allegedly knew of by 12 December 2024, to family members and acquaintances. Nine connected people allegedly made about C$6.8m (amf-allegation-reports-2026). No charges had been filed in the reports located. The company's release said the board, excluding Mr Pellerin, is reviewing the allegations with legal advisers and will cooperate with regulators if approached (terravest-pellerin-update-2026). The shares fell about 30% that day. No outcome of the board review or change to his role was found by 3 November 2026. The 19 June 2026 Faguy authorization motion has now been read for its allegations, parties and requested relief (terravest-faguy-authorization-2026-06-19); it names TerraVest, Pellerin and the certifying officers. It is a claimant pleading, not a finding or quantified award. The current court docket, exhibits and any authorization decision remain unverified. These are allegations, not findings. Even so, they concern the person with the largest stake and the board's chair. The company's response so far has been minimal.

Other evidence.

  • Negative: an insider-dominated board; two directors share a board with Clarke; the 2024 compensation committee was the whole board. The board sets no return criteria for management.

The three agency costs (Mauboussin and Callahan pp.47–48):

  • Control of resources: low because pay is small. However, each larger deal raises the operational and governance load on a very small team.
  • Risk tolerance: a 15% holder might be expected to take less risk than diversified owners want. Yet the Entrans purchase took leverage above the stated ceiling, so concentration did not produce caution.
  • Time horizon: long, with ten-year options and large holdings.

Buybacks in FY2026 (259,915 shares) exceeded share-based issuance (none in FY2026; 165,908 in FY2025). They are not merely offsetting compensation.

Agency cost and how the valuation treats it. The material agency cost is governance and key-person risk, not pay. Several outcomes are possible: a charge, a forced change of chairman, a large block sale (3.36m shares is about 59 days of the 3-month median TSX volume), reputational damage with sellers, or litigation costs. None changes the cash economics of the plants. Several could slow deal flow or raise the cost of capital. The model includes no fine, settlement or block-sale discount, because none is quantifiable from public evidence. The risk is recorded as a monitored trigger in 06-risks.md and valuation/prospective-checks.json; the scenario weights were not changed for it (see 11-scenario-probabilities.md).

Method: Mauboussin and Callahan, Capital Allocation (2025) pp.47–55, as cited in prompts/stages/05-management.md.

Capital allocation

The value driver is the cash management can redeploy after keeping the existing businesses healthy, and what that cash buys. This note measures what the last five years of cash actually did.

Money is C$ millions. Cash-flow statements were reviewed for FY2024 and FY2025 (terravest-fy2025-fs). For FY2021–FY2023 only the issuer's Cash Available for Distribution reconciliations were reviewed (terravest-fy2022, terravest-fy2023, terravest-fy2024), not the full statements, so those years lack investing and financing lines. 9M FY2026 totals come from the Q3 MD&A.

Sources and uses of cash

FY2021FY2022FY2023FY2024FY20259M FY2026
Operating cash before working capital (after interest and tax paid)46.968.396.6138.8173.6154.4
Working capital (absorbed −)−23.9−38.3−17.417.6−62.531.7
Operating cash flow23.129.979.2156.5111.1186.0
Maintenance capex (issuer)−5.8−8.0−14.9−26.1−26.8−34.4
Lease principal−4.4−5.8−5.8−8.3−12.5−11.9
Gross PP&E capex incl. rental fleet−55.8−66.7
PP&E disposal proceeds31.011.7
Acquisitions, net of cash acquired−149.1−857.6
Businesses sold4.33.0
Financial investments, NCI buyouts, intangibles−5.7−45.1
Net bank and term debt−45.8574.7
Shares issued (bought deals)91.9307.0
Options settled in cash, net−4.6−26.0
Buybacks00−30.0
Dividends−7.3−7.1−8.5−10.6−13.5−12.5
Net change in cash3.8−14.05.5
Closing cash (after FX)24.628.413.922.0

The cash balances reconcile: 24.6 + 3.8 + 0.0 FX = 28.4; 28.4 − 14.0 − 0.5 = 13.9; 13.9 + 5.5 + 2.5 = 22.0.

  • Operating cash before working capital and share compensation: 287.
  • Working capital: −61.
  • Net capex: −84, against 126 of D&A.
  • M&A: −117. Dividends: −37.
  • Debt: +81. Equity: −29. Other: −16.

What the table shows.

  • Until FY2023, TerraVest funded small deals and a modest dividend from internal cash and some debt, and kept capex below depreciation.
  • FY2024–FY2025 changed the scale. 1,006.7 of acquisitions was 3.2× the 312.4 of operating cash generated before working capital. It was funded by 528.9 of net new debt and 398.9 of new equity. The share count rose from 17.91m to 21.69m.
  • In FY2026 the priority reversed: cash went to deleveraging, small bolt-ons and the first buybacks in years.
  • Dividends stayed small, 10–12% of Cash Available for Distribution.
  • Option settlements (30.5 over two years) were a real financing cost that the issuer's CAD measure does not show.

Investment rates per sales change

Window FY2023 → FY2025 (Δsales 692.8), the two years with full statements; named steps in valuation/calculations.json:

RateNumeratorRate per ΔsalesStep
Incremental M&A rate (acquisitions net of divestitures)999.5144%incrementalMaRate
Fixed capital rate (net capex − PP&E depreciation)6.71.0%fixedCapitalRate
Fixed capital, gross (capex − disposals, before depreciation)79.711.5%netCapexFY2024To2025
Internally generated intangibles (no R&D disclosed; purchased intangibles)2.30.3%intangibleRate
Working capital, organic cash-flow basis44.96.5%organicWcRate
Working capital, balance sheet incl. acquired, FY2025 only137.1 on Δsales 459.329.9%balanceSheetWcRate

TerraVest invests almost entirely through acquisitions. Each dollar of added sales cost about C$1.44 of purchase price, and organic investment barely exceeded replacement. That is the inflection, and it came in FY2025 with Entrans. The same team was in charge (Haw as CEO, Gilbert as CIO, Pellerin as Executive Chairman); the CFO changed in 2025. The balance-sheet working-capital rate (30%) overstates the run rate, because it holds Entrans's full year-end balances against 6.5 months of sales. On a cash basis organic working capital was 6.5% of the sales change, consistent with the 120–130 inventory days in 01-business.md. FY2026 has released 31.7 so far, mainly customer deposits on data-centre work, which will reverse as projects ship.

Reinvestment and returns

Owner earning power (cash NOPAT, baseline definition):

  • FY2024: 103.0. FY2025: 149.3 (cashNopatFY2024, cashNopatFY2025).
  • TTM June 2026: 166.0.

Reinvestment rate, FY2024–FY2025.

  • Growth investment: 999.5 of net acquisitions + 26.7 of growth capex beyond maintenance and disposals + 44.9 of organic working capital = 1,071.1.
  • Against 252.3 of matching cash NOPAT, the reinvestment rate is 425%.

Incremental return, lagged.

  • Cash NOPAT rose 63.0 from FY2024 to TTM June 2026, against about 1,092 of capital deployed in FY2025 and H1 FY2026 (869.0 of FY2025 deals net of cash, business sales and the 48.3 earnout reversal; 132.9 in H1 FY2026; 28.1 of FY2025 growth capex; 62.5 of working capital; Q3 deals excluded). That is about 5.8%.
  • The matched deal-by-deal measurement (research/07-assumption-register.md, 3 November) finds 16.6× achieved (6.0%), or 12.05× (8.3%) after allowing for deals still in their restructuring ramp.
  • Both are below a 9–10% cost of capital. A rolling three-year lagged ROIIC is not yet meaningful: the capital is less than two years old and 80% of it is one cyclical deal. Judging Entrans fifteen months after closing would confuse a trailer trough with permanent capital inefficiency (Mauboussin and Callahan pp.46–47).

Identity check. FY2025 NOPAT growth was 45% (103.0 → 149.3). FY2025 growth investment of about 945 equals 9.2× the prior year's NOPAT. Growth ≈ reinvestment rate × return implies about 4.9% earned within the year on new capital. That is consistent with Entrans contributing 6.5 months at trough-ish trailer earnings, so the definitions hold. Operating leverage was not the source: incremental cash NOPAT per sales dollar in FY2025 was 10.1% (operatingLeverageFY2025), below the 11.3% FY2024 margin. The acquired businesses diluted margins. Durable capital efficiency, not margin, is the open question.

Mix and returns by use.

  • Acquisitions: 93% of growth investment, earning 6–8% so far (above).
  • Organic growth capex (fibreglass capacity, rental fleet) and working capital: about 7%, earning on the order of 13.1 of extra EBITDA at constant margin from FY2024 to TTM. Organic EBITDA growth is a margin-held estimate; unit-level capex returns are not disclosed.
  • Payouts: dividends about 2% of uses; FY2026 buybacks at C$115 average.

Acquisition record

DateBusinessStakePrice (C$m)Multiple and later result
Oct 2023LV Energy (via GES)67%25.0Undisclosed; sister company resold for 4.3
Apr 2024Advance Engineered Products100%33.6Undisclosed; tank trailers
Jan 2025Aureus (via GES), assets67%in FY2025 totalHot-oiling line resold for 3.0
Mar 2025Entrans100%779.6 cash (+ up to US$46m earnout, reversed)About 7.0× after-rent TTM EBITDA (about 9.9× NOPAT); now about half its purchase EBITDA; missed its earnout
Apr–May 2025LBT (EV ~US$16m), Simplex (EV ~US$28m), Tankcon (EV ~C$27.8m)100%in FY2025 total 960.5Simplex feeds the data-centre platform; LBT and Tankcon add to trailers
Sep 2025Wave (via GES)smallIntegrated
Jan 2026KBK Industries100%125.2About 5.6× after-rent TTM EBITDA
H1 FY2026Three small deals, one 60% owned9.1
May–Jul 2026Colter (via GES; bargain-purchase gain about 5.0), B&R, Jet Peinture, SPV (23.4)Colter/B&R/Jet undisclosedSPV debt-funded; outside the June TTM

Aggregate. Over FY2024 to TTM June 2026 (matched to ownership months), capital of 964.2 earned 58.2 of TTM NOPAT: 16.6× achieved, 12.05× after allowing for the restructuring ramp (achievedMultiple, matureMultiple).

  • Margin bounds: acquired EBITDA is the change in group EBITDA less organic growth at the FY2024 margin. The base portfolio has roughly 975 of sales at the window's end, so one margin point is about 9.8 of EBITDA. If its margin was one point higher at the end (plausible with data-centre volume), the achieved multiple is about 18.2×; one point lower (the base trailer business) gives about 15.2×.

Deployment pace. Net acquisition capital was 158.8 in FY2024, 869.0 in FY2025 (with a C$307m equity raise) and 132.9 in H1 FY2026, plus SPV's 23.4 and undisclosed Q3 deals. The model deploys nothing in year 1 while debt falls to the ceiling, then 110–167 a year in years 2–5 (base). That is within the observed non-equity pace and implies no new equity.

Current funding position

Starting net bank debt is 860.3 (June 2026 bank debt less cash of 836.9, plus the July SPV purchase of 23.4). At TTM EBITDA of 312.2 the 2.4× ceiling allows 749.2, so TerraVest needs to delever before debt-funded deployment resumes; the base makes no new acquisition in year 1. Interest, dividends and the carried earnout and vendor claims (8.6) are paid before the acquisition budget. New deals start at 63.08% of mature earnings and ramp to 100% over three years, and future deal EBITDA does not raise the borrowing ceiling. The pension deficit (4.3) is a terminal claim. Fair-value investments (56.5, March 2026) are credited once. Term loans of 100 (March 2027) and 46.4 (March 2028) fall due inside the forecast. In June 2026, C$120.1m of the revolver was undrawn.

Capital-efficiency diagnostics: research/10-capital-efficiency.md.

Revenue, operating cash and FY2024–FY2025 deal cash reconcile to our facts.

  • FY2014–FY2024 (eleven years, from the first deal year to the year before Entrans): mean 0.88×, median 0.92×. Five years exceeded 1.0× (FY2017 1.43, FY2018 2.05, FY2021 1.67, FY2022 1.26), funded by debt. Including FY2012–FY2013, which had no deal cash, the mean is 0.75×.
  • Quiet years (under a quarter of the mean) were FY2016 (0.06×) and FY2020 (0.19×), never consecutive; FY2023 was close at 0.23×. FY2025 (Entrans, 7.72×) was funded by debt and equity and sits outside the budget the model can deploy (stage 6 perimeter rule).

Comparison with the model: the base deploys 0, then 0.64× rising to 0.85× of cash earnings, and 0.81–0.95× of free cash flow after interest, up to the 2.4× ceiling on existing-business EBITDA. That is within the record (0.75–0.88× mean, 0.92× median) on the nearest matching definitions. The binding constraint is the leverage ceiling, not deal supply. Year one is quiet because leverage is above the ceiling, which is evidenced timing. The downside's four-year dry spell exceeds the record's longest quiet run of one year. The base already sits at the expected budget, so no input changed. If future acquired EBITDA were allowed to raise borrowing capacity, the base would exceed the record, and it would then need a yearly budget path stating the expected deal supply.

Thesis and valuation

Current assessment:5November2026, after source reconciliation of the revenue-to-owner-cash bridge.

TerraVest buys niche industrial manufacturers, improves their operations and reallocates cash into further purchases. Tank-trailer recovery can offset data-centre/heating/energy cyclicality, so the accepted source framework uses zero net organic sales growth. Profitable growth comes from funded acquisition sales and their explicit cash margins, with debt capacity tied to the existing business.

Current valuation

Saved quote CAD 106.84, market time 2026-11-04T21:00:00.000Z; fixed valuation date 5 November 2026 and original model exits. These are forward estimates.

HorizonBearBaseBullWeighted cash-flow IRR
5 years-11.20%7.98%12.24%4.66%
10 years-3.03%10.19%15.65%9.09%

Reported trailing revenue of CAD 1,731.218m now drives annual NOPAT and EBITDA margin paths. The prior earnings-factor forecast was first reproduced mechanically before updating estimates. Highland’s 11 owned months and KBK’s issuer nine-month pro-forma sales supply a labelled annual-sales proxy; purchase capital includes transaction fees. KBK adds only CAD 46.416m sales missing from the trailing baseline, with seller-derived cash still recovering over three years. SPV sales remain a separately labelled small-deal price/sales estimate.

Pre-mortem

Highland flat-month annualization and KBK pro-forma annualization are estimates with seasonality limits. SPV sales are not reported by the issuer and are estimated from its funded price and matched small-business economics. Margin recovery, target-specific maintenance/rent, bank refinancing, governance and limited small-deal supply remain material uncertainties. The 2.4× modeled borrowing ceiling is not an actual loan covenant. The central estimate can fail even when a useful product or good acquisition history survives. Customer demand, supplier pricing, the capital needed for delivery and ownership/financing claims must all work together. The adverse case is a representative failure mechanism, not the largest possible loss. No new report or positive share-price move alone resolves these risks.

Exit multiple

Current17x central/upside and 13× adverse EV/cash-NOPAT are separate current judgments, with current bank debt, claims, non-operating assets and option proceeds accounted once. The revenue bridge does not supply independent proof of terminal value or remove the survival risks identified in the written debate. Shorter duration, poorer cash conversion and higher required returns remain relevant stresses. Historical source reproduction and current underwriting remain distinct.

Bear case

Highland flat-month annualization and KBK pro-forma annualization are estimates with seasonality limits. SPV sales are not reported by the issuer and are estimated from its funded price and matched small-business economics. Margin recovery, target-specific maintenance/rent, bank refinancing, governance and limited small-deal supply remain material uncertainties. The 2.4× modeled borrowing ceiling is not an actual loan covenant. The existing adverse operating and capital-allocation paths remain the coherent modeled stress. Matching sales to cash prevents a missing denominator from hiding those assumptions; it does not turn a proxy margin or assumed refinancing into a reported fact. Debt, deferred claims, operating liquidity and distributions remain funded in the same cash ledger.

Variant view

The market's belief appears to be: a proven serial acquirer, temporarily discounted for a chairman's personal legal problem and a trailer downturn. This study broadly agrees, with one difference. One large, peak-cycle purchase (Entrans, 80% of recent capital) is earning 4–9% and drags the measured cohort to 12–17× NOPAT (04-capital-allocation.md). At about 19× cash NOPAT, today's price capitalizes TerraVest as a compounder that keeps buying small deals well. On that base the expected return is about 8–10% a year, near the hurdle. No mispricing in our favor: the June fall removed a premium rather than creating a clear discount. Upside needs restructuring on top (12.0% / 15.5%) or an Entrans recovery, which is not modeled and would add to existing earnings. A repeat of a large peak-cycle deal, or a governance shock that stops deal flow, would move the outcome toward the downside. There is no hard catalyst.

The source bridge correction changes the central estimate by only a small amount at the same price/date. It does not establish a new market mispricing or justify an unsupported advocate sensitivity. The independent claim judgment still sets the evidence burden; the current numerical returns are the table above.

Why the opportunity exists

The following observations retain the measurement dates in their cited sources; no new holder, liquidity or short-interest survey is claimed.

Neglect is no longer the explanation:

  • Market capitalization is about C$2.31bn (21.43m shares at C$107.85). Three-month median TSX volume is about 56,900 shares, or C$6.5m a day (yahoo-tvk-trading-2026-11).
  • Short interest and retail ownership were not checked (gap).

The sellers had specific reasons:

  • 5 June 2026: the AMF allegations, with the stock down about 30% in a day on about 14× normal volume.
  • A visible trailer downturn: Compressed Gas Q3 EBITDA −42%.
  • The Entrans earnout reversal, showing the big deal missed its own targets.

The discount is largely justified by business evidence, not just by fear. A buyer today pays about 19× for a company whose marginal capital earns about 6–8%.

What would prove us wrong

The next FY2026 issuer report and subsequent debt disclosures: actual KBK/SPV revenue and cash contributions, Entrans margins, maintenance/leases, deposits, all-in prices and 2027/2028 refinancing requirements. The next results date was not confirmed in checked evidence. Compare future observations with the same ownership, cost and reporting periods used in this model. Preserve earlier frozen checks and score them as their reports arrive; do not edit their forecasts to match the result. Unavailable deal disclosure needs a bounded estimate and a revision trigger, not a claim of observed target profitability.

Source bridge and same-price/date changes. The earlier initial completion audit’s three revenue gaps are now closed with reported observations and explicit estimates; the remaining limits above are ordinary underwriting uncertainty, not missing forecast outputs.

Risks & disconfirming evidence

Paths to permanent loss

  1. Reinvesting below the cost of capital. This is the main one. The FY2024–TTM deal cohort earns 12–17× NOPAT (6–8% after tax) against a 9–10% hurdle (04-capital-allocation.md). If future deals price like Entrans and earnings stay at today's cycle point, every dollar redeployed destroys value while reported EBITDA grows. This is a value trap, and it would not show in issuer Cash Available for Distribution or adjusted EBITDA growth.
  2. Governance and key person. The Executive Chairman (15.5% holder) is under AMF investigation for alleged tipping before the Entrans acquisition. Possible outcomes are a charge, his removal, a block sale (about 59 days of median volume), reduced trust among founder-sellers, and litigation (the 19 June 2026 Faguy authorization motion names the issuer and officers; its allegations and requested relief are now read, but no later court decision or quantified issuer liability is established). None is in the model.
  3. Structural decline in legacy lines. Electrification pressure on propane and heating oil, and cast-iron boilers losing out to high-efficiency appliances, could shrink the replacement core faster than its low single-digit drift.
  4. Data-centre concentration. About 22 of annualized EBITDA comes from recent project volume with a few concentrated EPC customers. If it fades, that is a give-back of about 7% of EBITDA. Customer deposits (part of the 31.7 working-capital release in 9M FY2026) would reverse at the same time.

Unverified inputs (largest first)

  • Base deal multiple, 7.40×. It rests on two issuer-stated small-deal multiples (Highland 4.0×, rent treatment unstated; KBK 5.6× after rent). It assumes future deals are bolt-ons whose earnings hold at the sellers' trailing level. A return to Entrans-scale or Entrans-priced deals would invalidate it (9.87–12.05×).
  • Exit multiple, 17×. It sits inside the Koller range for small-deal base economics (15.6–21.0×) and at the stock's own recent low (05-thesis.md). At 14× the five-year base falls to 2.8% (weighted 1.7%).
  • Segment economics. The split of HVAC between tanks and heating, and of Compressed Gas between trailers and stationary tanks, is estimated, not disclosed.
  • Claims and assets. Carried March 2026 contingent claims (8.6), pension (4.3) and financial investments (56.5).
  • KBK and SPV cohort NOPAT (7.14 at KBK's own multiple; 3.16 at the small-deal multiple). These are estimates, not issuer disclosures.
  • Lease interest (17.6, Q2 × 4) and the 25% normalized tax rate.
  • Annual history. Full FY2021–FY2023 cash-flow statements were not retrieved, so five-year sources and uses are partial for those years.

Disconfirming evidence to watch

EvidenceSource and timingWhat it would mean
Compressed Gas adjusted EBITDA staying below about 70 a year through FY2027Quarterly MD&ATrough is structural; the downside deal multiple becomes the base
A new large deal at ≥ 7× after-rent EBITDA, funded by debt above 2.5×Acquisition releases, MD&AReinvestment risk rising; value trap path
Equity issued below C$100Issuer releasesPermanent dilution in a downturn
AMF charges or the board review's outcome; chairman changeAMF, issuer releasesGovernance path; possible deal-flow and cost-of-capital effects
HVAC base-portfolio sales falling year over yearQuarterly MD&AData-centre fade
Maintenance capex above about 50 a yearCAD reconciliationEarning power overstated

Earlier risk notes remain valid. Larger or more competitive deals can raise purchase prices. Restructuring can take longer or yield less. Inventory and customer deposits move reported cash without changing durable earning power. Issuer CAD is after financing costs and cannot be put into an EV/NOPAT multiple. Accounting gains (the 48.3 earnout reversal, bargain purchases) are not recurring cash.

Surviving debate attacks — 5 November 2026

Low; small-deal economics conditional, refinancing/governance unresolved and revenue-to-owner-cash forecast incomplete. Reconstructed the independent isolated stress at the same quote/date/horizons; do not treat stress size as a probability or a measured current fact. Reconstructed the independent isolated stress at the same quote/date/horizons; do not treat stress size as a probability or a measured current fact. Reconstructed the independent isolated stress at the same quote/date/horizons; do not treat stress size as a probability or a measured current fact.

Discriminating evidence: Next FY2026 report/debt maturity disclosures: Entrans earnings, maintenance capital and deposits, all-in small deal prices, March2027/2028 refinancing. The complete debate sizes these risks using the shared forecast; a sensitivity is neither a measured fact nor a calibrated probability.

Revenue bridge closure and remaining uncertainty — 5 November 2026

The previously missing sales/cash perimeter is now modeled. Highland flat-month annualization and KBK pro-forma annualization are estimates with seasonality limits. SPV sales are not reported by the issuer and are estimated from its funded price and matched small-business economics. Margin recovery, target-specific maintenance/rent, bank refinancing, governance and limited small-deal supply remain material uncertainties. The 2.4× modeled borrowing ceiling is not an actual loan covenant. The next FY2026 issuer report and subsequent debt disclosures: actual KBK/SPV revenue and cash contributions, Entrans margins, maintenance/leases, deposits, all-in prices and 2027/2028 refinancing requirements. The next results date was not confirmed in checked evidence. This closes the missing forecast output rather than claiming that the target economics or refinancing outcomes are certain. Earlier source-gap statements in the dated debate describe its initial information set; current inputs are in 07-assumption-register.md.

Current assumption register

Assessment:5November2026. Reported facts, issuer pro-forma estimates, normalization and forward judgments remain separately classified.

Reported starting bridge

Reported trailing revenue of CAD 1,731.218m now drives annual NOPAT and EBITDA margin paths. The prior earnings-factor forecast was first reproduced mechanically before updating estimates. Highland’s 11 owned months and KBK’s issuer nine-month pro-forma sales supply a labelled annual-sales proxy; purchase capital includes transaction fees. KBK adds only CAD 46.416m sales missing from the trailing baseline, with seller-derived cash still recovering over three years. SPV sales remain a separately labelled small-deal price/sales estimate.

InputValueClassificationDefinition/evidence
revenue1731.218derived reportedFY2025 plus9M2026 less9M2025:1371.151+1311.809−951.742=1731.218 CADm. Acquired sales already consolidated remain inside this baseline; only missing contribution is added. Sources: terravest-fy2025, terravest-q3-2026

Known and committed cohort bridge

Revenue is consolidated gross; cash is on the model’s common-owner or cash-NOPAT perimeter. A reported sales observation is not a reported cash margin. Missing months exclude sales already in the starting baseline. Capital already paid or reserved is not purchased again.

CohortMissing annual salesMissing/mature cashTiming and basis

Forward scenario mechanisms

TerraVest buys niche industrial manufacturers, improves their operations and reallocates cash into further purchases. Tank-trailer recovery can offset data-centre/heating/energy cyclicality, so the accepted source framework uses zero net organic sales growth. Profitable growth comes from funded acquisition sales and their explicit cash margins, with debt capacity tied to the existing business.

Current17x central/upside and 13× adverse EV/cash-NOPAT are separate current judgments, with current bank debt, claims, non-operating assets and option proceeds accounted once.

base

Pay interest, dividends and identified vendor/earnout claims before deploying capacity. Existing-business net debt capacity remains 2.4× EBITDA; new deals are small (the deployment budget cannot buy another Entrans) and are priced at the sellers’ trailing earnings on Highland and KBK’s issuer multiples (7.40× mature NOPAT), reaching that level over the three-year ramp with no restructuring uplift. Value terminal cash NOPAT at the original 17× EV multiple. Revenue and cash margins are now explicit yearly paths with matched purchased sales; current KBK missing months and all-in costs replace the old half-year shortcut.

DriverValue/pathReason and sources

downside

Borrowing capacity falls with earnings, stopping deals while debt exceeds the ceiling. The original 13× EV/NOPAT multiple prices the reduced earning power. Revenue and cash margins are now explicit yearly paths with matched purchased sales; current KBK missing months and all-in costs replace the old half-year shortcut.

DriverValue/pathReason and sources

upside

Keep zero organic growth, the three-year ramp, the 2.4× existing-business debt ceiling and the 17× exit. This isolates better purchase economics; it adds no leverage, free growth or rerating. Revenue and cash margins are now explicit yearly paths with matched purchased sales; current KBK missing months and all-in costs replace the old half-year shortcut.

DriverValue/pathReason and sources

Estimation limits and revision triggers

Highland flat-month annualization and KBK pro-forma annualization are estimates with seasonality limits. SPV sales are not reported by the issuer and are estimated from its funded price and matched small-business economics. Margin recovery, target-specific maintenance/rent, bank refinancing, governance and limited small-deal supply remain material uncertainties. The 2.4× modeled borrowing ceiling is not an actual loan covenant.

The next FY2026 issuer report and subsequent debt disclosures: actual KBK/SPV revenue and cash contributions, Entrans margins, maintenance/leases, deposits, all-in prices and 2027/2028 refinancing requirements. The next results date was not confirmed in checked evidence.

Named arithmetic, stable fact IDs and source links are retained in valuation/calculations.json. Inputs were selected before inspecting the revised IRR; the earlier source result and prior models are not overwritten.

Underwriting plan

Written from the evidence in 01-business.md through 04-capital-allocation.md. The review moved the base and upside deal multiples to the deal size the model can actually deploy into. Money is C$ millions; the forecast vintage starts 26 October 2026.

Opportunity ledger

OpportunityStarting pointCustomer need and why TerraVest winsReachable scale in five yearsInvestment and cash costTiming and limitsEvidence against
Tank-trailer recovery (Entrans, LBT, Tankcon, Advance, SPV)Acquired trailer EBITDA about 56 TTM against about 111 at purchase; Compressed Gas Q3 FY2026 17.3 vs 29.7Carriers must replace aging fuel, chemical and food-grade fleets; Entrans brands lead in tank trailersRecovery to purchase-level EBITDA adds about 55 EBITDA, about 29 NOPAT (+18% on the baseline)None beyond working capital as volume returns (about 6.5% of the sales change)Trailer cycles have run two to four years; ACT shows depressed September 2026 ordersTariff pull-forward may have borrowed demand; the earnout miss shows the sellers' own targets failed
Data-centre fuel storage and fuel systems (Highland, Simplex, KBK, other plants)HVAC base-portfolio sales +61% in Q3 and +23% for 9M FY2026; about 22 of annualized EBITDA from the increaseBackup generators need on-site fuel tanks; capacity and steel-buying scale let TerraVest deliver large projectsHolding today's level is the base; growth would need new fibreglass and steel capacityQ3 FY2026 growth capex 9.4, mainly fibreglass capacity; customer deposits fund part of the working capitalProject-driven; management expects strength "in the near term" onlyHyperscale capex cycles; concentrated EPC customers; deposits reverse as projects ship
Heating appliances (ECR, Granby)About 10–14% of profitInstaller loyalty; replacement in older homesDeclining low single digits a yearMinimalOngoingElectrification; single-source heat exchangers
Western Canadian services (GES/Fraction, Colter)Service 9M FY2026 EBITDA 52.8, +12%; one-third minority-ownedWater management and flowback for large producers; integration of LV, Aureus and ColterShare gains possible; activity follows oil and gas pricesService capex near its D&A; maintenance rose to 14.4 in Q3 FY2026Seasonal (first half), cyclicalCommodity-driven activity; minorities take a third
AcquisitionsObserved net capital 158.8 (FY2024), 869.0 (FY2025, equity-funded), 132.9 (H1 FY2026) plus SPV 23.4Retiring founders want continuity; TerraVest's purchasing and plant network raise acquired marginsBase deploys about 559 over five years (0, 110, 133, 149, 167) at 7.40× → about 76 of mature NOPATInternally generated cash after interest, dividends and claims, with net debt pinned at 2.4× existing EBITDA (749); no new equityYear 1 deleverages from 2.76×; term loans of 100 (Mar 2027) and 46 (Mar 2028)Recent cohort earns 12–17×; governance reputation risk with sellers; private equity competition on larger targets
Buybacks (ASPP from 19 Oct 2026)30.0 spent at C$115 average in 9M FY2026—Not modeled; would compete with deleveraging and dealsCash at the share priceDiscretionaryAccretive only below value; the base values the stock near today's price

Overlap. The base holds the TTM earning power flat (zero organic growth). That implicitly nets the trailer recovery (+29 NOPAT if it comes) against data-centre fade, heating decline and Western Canadian cyclicality, without assuming any of them. Bought earnings enter only through the acquisition engine at the stated multiple, and known cohorts (KBK's missing half-year, SPV) are added once. The TTM is not obviously inflated. Q3, usually the weakest quarter, produced the highest adjusted EBITDA of the last eight (87.0), though with Compressed Gas at its lowest.

Absolute scale, base, year 5 (October 2031). NOPAT 218.8 against 166.0 today. Deals add about 76 of mature NOPAT on about 559 of capital, partly still ramping at exit. At the group's 0.53 NOPAT/EBITDA conversion and 18% EBITDA margin, that is about 140 of EBITDA and about 790 of revenue. Group revenue would be about 2,500, almost half above today, with no organic growth. Deployment of 110–170 a year is roughly one KBK or Highland-sized deal plus bolt-ons each year. That matches the FY2024 pace without equity, and is the deal size the 7.40× multiple was measured on. Net debt stays at 749 and leverage falls as EBITDA grows. Nothing here needs more staff at head office than TerraVest has used before, but a deal the size of Entrans is outside the base.

The base's 7.40× (13.5% mature yield, no restructuring) sits just below that expectation, near the 2014–2022 record (7.2×).

Scenario mechanisms

DownsideBaseUpside
Existing earning powerHalves in year 1 (83.7), recovers to 75% by year 3 (131.0) and stays thereFlat at TTM 166.0 plus KBK/SPV rampsFlat, as base
Organic growth000
Deal ramp63% → 100% over three yearssamesame
DeploymentStops: debt above the falling ceiling; 15.8 by year 50 in year 1, then 110–167 a year0 in year 1, then 110–195 a year
Leverage ceiling2.4× of a lower EBITDA2.4×2.4×
Financing and dilutionNo equity; existing options onlysamesame
Exit (EV / cash NOPAT)13×17×17×
5y / 10y XIRR at C$107.85 (3 Nov 2026)−11.4% / −3.1%7.7% / 10.1%12.0% / 15.5%

Mechanisms.

  • Base. Today's earning power holds, with cyclical gains and losses netting to zero. TerraVest keeps buying bolt-ons at the prices it paid for Highland and KBK, and bought earnings hold at the sellers' trailing level with nothing from restructuring. The base needs no trailer recovery. Entrans's own recovery would be upside to existing earnings and is not modeled. Another Entrans-scale, peak-cycle purchase would break the base (see 05-thesis.md, what would prove us wrong).

Funding. Every deal is funded from cash after interest at 6%, dividends of C$0.80 a share and the carried claims, before any contribution, with a one-year delay. Debt never exceeds the ceiling, so the engine cannot repeat FY2025's equity-funded jump. The model omits the cost of refinancing the 2027 and 2028 term loans; it assumes they roll at 6%.

Adapter. capital-acquirer: debt-capacity-limited redeployment at a stated mature multiple, with a restructuring ramp and an EV/NOPAT exit. Its cost is that organic growth is fixed at zero and buybacks are not modeled. Each input's classification, sources and reasoning are in the inputNotes of valuation/model.json.

Revenue bridge closure — 5 November 2026

Reported trailing revenue of CAD 1,731.218m now drives annual NOPAT and EBITDA margin paths. The prior earnings-factor forecast was first reproduced mechanically before updating estimates. Highland’s 11 owned months and KBK’s issuer nine-month pro-forma sales supply a labelled annual-sales proxy; purchase capital includes transaction fees. KBK adds only CAD 46.416m sales missing from the trailing baseline, with seller-derived cash still recovering over three years. SPV sales remain a separately labelled small-deal price/sales estimate.

5-year base revenue 2250.119, operating owner cash 219.198 (CADm). 10-year base revenue 3474.947, operating owner cash 356.554 (CADm). The original customer/opportunity and acquisition-budget reasoning remains; this correction does not infer new demand from a matched denominator. Highland flat-month annualization and KBK pro-forma annualization are estimates with seasonality limits. SPV sales are not reported by the issuer and are estimated from its funded price and matched small-business economics. Margin recovery, target-specific maintenance/rent, bank refinancing, governance and limited small-deal supply remain material uncertainties. The 2.4× modeled borrowing ceiling is not an actual loan covenant.

Source arithmetic and old/new inputs.

Capital productivity and reinvestment

Assessment:5November2026. These are shared-engine diagnostics from the same owner-cash projection shown in the dashboard, not a new historical measurement. Money is in CAD millions.

HorizonScenarioReturn/proxy definitionRatePeriod-weighted reinvestmentNew growth capitalMatching earningsFunding residual
5 yearsdownsideAcquisition ROIIC · mature cash proxy6.22%2.80%16.407586.8091.71e-13
5 yearsbaseAcquisition ROIIC · mature cash proxy13.53%59.30%560.118944.4851.14e-13
5 yearsupsideAcquisition ROIIC · mature cash proxy21.44%61.34%609.774994.1411.14e-13
10 yearsdownsideAcquisition ROIIC · mature cash proxy6.22%39.45%513.1221300.6032.27e-13
10 yearsbaseAcquisition ROIIC · mature cash proxy13.53%73.40%1776.2362419.8220.00e+0
10 yearsupsideAcquisition ROIIC · mature cash proxy21.44%78.44%2341.2712984.8570.00e+0

Reported trailing revenue of CAD 1,731.218m now drives annual NOPAT and EBITDA margin paths. The prior earnings-factor forecast was first reproduced mechanically before updating estimates. Highland’s 11 owned months and KBK’s issuer nine-month pro-forma sales supply a labelled annual-sales proxy; purchase capital includes transaction fees. KBK adds only CAD 46.416m sales missing from the trailing baseline, with seller-derived cash still recovering over three years. SPV sales remain a separately labelled small-deal price/sales estimate.

Reinvestment is total new growth investment divided by total matching earnings, not an average of annual percentages. Previously funded cohort contributions are not new investment returns. Acquisition cash-yield proxies and forecast-implied productivity are not measured historical ROIIC or project IRRs. All dividends, existing claims, liquidity and financing are reconciled before new purchase capital.

Highland flat-month annualization and KBK pro-forma annualization are estimates with seasonality limits. SPV sales are not reported by the issuer and are estimated from its funded price and matched small-business economics. Margin recovery, target-specific maintenance/rent, bank refinancing, governance and limited small-deal supply remain material uncertainties. The 2.4× modeled borrowing ceiling is not an actual loan covenant.

Historical measurements and definitions remain in 04-capital-allocation.md and valuation/calculations.json. Dated source bridge and funding ledger.

Scenario probabilities

Assessment date: 2026-10-27. These are initial subjective judgments, with low confidence. Financial sources support the mechanisms, not measured numerical odds. The original authors did not provide or endorse these weights.

HorizonDownsideBaseUpside
5 years30%50%20%
10 years35%40%25%

5-year reasoning: The acquisition/restructuring framework and cash generation support the central path, while opening leverage above the stated acquisition ceiling leaves meaningful cyclical and financing sensitivity. A recovery of acquired earnings to purchase-date levels is possible but not yet evidenced.

10-year reasoning: Longer industrial cycles and a growing cumulative purchase budget widen the distribution. Give less weight to uninterrupted central execution, without assuming rising leverage or a larger exit multiple.

Downside: A cyclical earnings shock contracts both cash generation and debt capacity. The accepted source stress is a representative adverse path, not a 30% issuer default probability or a maximum loss.

Base: Normalized operating cash, deleveraging and small bolt-on purchases at the sellers’ trailing earnings (7.40×), with no restructuring uplift, support base. Zero further organic growth and fixed existing-business debt capacity limit reliance on free expansion.

Review triggers:

  • Normalized segment cash earnings and industrial demand.
  • Net debt versus the existing-business debt ceiling.
  • All-in deal cost, restructuring spending and realized cohort NOPAT.

Each path represents a broad outcome region, not the probability of hitting an exact share price or IRR. Paths are a coarse approximation of a continuous joint distribution; the displayed downside and upside are not bounds. Joint driver dependencies must be considered, rather than multiplying marginal driver guesses. Scenario weights sum to 100% within this approximation. Severe outcomes remain possible outside the modeled paths.

Price movement alone does not change these weights. A changed causal premise, acquisition capacity, financial report or scenario definition does. Local assumption sensitivities suspend the researched weights until the full distribution is reassessed. No weighted-average IRR is presented as an expected shareholder return.

Method: Damodaran, chapter 33, printed pp.894-897. See valuation/model.json for machine-readable weights and docs/method/cash-flow-and-reinvestment.md for the capital definitions.

3 November 2026: scenario definitions after deal re-underwriting

The paths keep their causal roles, but the purchase economics are redefined. Base buys at 9.87×, the issuer's purchase prices on the sellers' trailing EBITDA, with acquired earnings recovering to that level and no restructuring uplift. Downside buys at the measured FY2024–TTM June 2026 mature-equivalent 12.05×, which embeds today's trailer trough. Weights are unchanged at 30/50/20 (five years) and 35/40/25 (ten years). The new evidence lowers the purchase yield in every path. It does not show that the cyclical downside or a trailer recovery is more or less likely; the Q3 Compressed Gas decline is already in the TTM baseline. Calculation and sources: 07-assumption-register.md and valuation/calculations.json.

3 November 2026: pipeline review of the weights

Reviewed after completing the eleven-stage research pipeline, including the governance evidence that the 27 October assessment did not record. On 5 June 2026 the Executive Chairman became the subject of a reported AMF investigation (03-management.md). Weights are unchanged at 30/50/20 (five years) and 35/40/25 (ten years). Reasons:

  • The allegation concerns personal trading, not the company's cash, accounts or plants. Its plausible effects (slower deal flow, a block sale, a higher cost of capital, litigation cost) act through deployment and valuation more than through the operating path that separates the three scenarios. The downside already stops deployment.
  • The new pipeline evidence points both ways. The trailer trough and the below-hurdle cohort returns are already priced into the downside and base deal multiples. Q3 FY2026 produced the highest adjusted EBITDA of the last eight quarters, and Service and data-centre volume are growing. Nothing in the new work is a causal change to the probability of a joint industrial and energy recession.
  • The exit-multiple finding (base 17× is at the top of what base returns justify) is a valuation sensitivity inside the base, not evidence for a different path. It is reported separately (05-thesis.md), not folded into the weights.

Review triggers added: an AMF charge or change of chairman; Compressed Gas adjusted EBITDA below about 70 for FY2027; a refinancing of the March 2027 term loan materially above 6%.

3 November 2026: small-deal review (scenario definitions changed, weights reassessed)

The causal roles are unchanged: purchase economics only, with the same operating paths, leverage, exit multiples and zero organic growth. Weights stay at 30/50/20 and 35/40/25:

  • ECR, and the absence of disclosed post-deal results for KBK, keep it below the base.
  • The downside's cyclical shock is unaffected by deal size.

Source bridge review — 5 November 2026

The revenue-to-cash coverage gap is closed. Reported trailing revenue of CAD 1,731.218m now drives annual NOPAT and EBITDA margin paths. The prior earnings-factor forecast was first reproduced mechanically before updating estimates. Highland’s 11 owned months and KBK’s issuer nine-month pro-forma sales supply a labelled annual-sales proxy; purchase capital includes transaction fees. KBK adds only CAD 46.416m sales missing from the trailing baseline, with seller-derived cash still recovering over three years. SPV sales remain a separately labelled small-deal price/sales estimate. Existing horizon-specific weights were reassessed and retained: the core joint demand/capital scenarios have not been replaced and exact numerical frequency evidence has not appeared. Highland flat-month annualization and KBK pro-forma annualization are estimates with seasonality limits. SPV sales are not reported by the issuer and are estimated from its funded price and matched small-business economics. Margin recovery, target-specific maintenance/rent, bank refinancing, governance and limited small-deal supply remain material uncertainties. The 2.4× modeled borrowing ceiling is not an actual loan covenant. These are subjective estimates, not measured odds.

Bull–bear review — TerraVest, 5 November 2026

Subsequent source closure: the missing revenue bridge identified in this debate has now been completed. Current source-derived estimates, corrections and same-price/date effects. The original independent argument record below is retained with its information set; it is not a claim that all estimated target margins have become reported facts.

Independent advocates prepared opening cases without seeing the other draft, then exchanged point-by-point cross-examinations. A separate judge who did not author the prior model assessed the competing claims. Source reconstructions retain their stated provenance; inaccessible private reports were not newly read. Quoted sensitivities test arguments and are not automatically adopted forecasts.

Fixed quote CAD 106.84, market time 2026-11-04T21:00:00.000Z; valuation date 2026-11-05. Original forecast exits retained.

HorizonBefore bear/base/bullAfter bear/base/bullWeighted before → after
5 years-11.24% / 7.94% / 12.19%-11.24% / 7.94% / 12.19%4.62% → 4.62%
10 years-3.05% / 10.16% / 15.62%-3.05% / 10.16% / 15.62%9.06% → 9.06%

Bull case

As of 5 November 2026. No opposing advocate draft was read. Existing company research, fact/calculation ledgers and exact registered source locators were examined; original issuer sources additionally checked live: Lumine Q3, CSU Q2, Diploma Q3 transcript, NVIDIA CFO commentary, TerraVest Highland/KBK, WOSG FY26. Harvia Q3 PDF retrieval failed; its registered extraction remains the evidence limit. Private source interpretations below are the repository's documented reconstruction, not a new claim to have read an unavailable private original.

The strongest bear case is that Entrans consumed most recent capital at peak-cycle earnings, leaving leverage and concentrated industrial exposures precisely when trailer demand weakens. Chairman-related allegations add governance and funding uncertainty; neither a low entry multiple nor a good earlier cohort resolves that.

Test the existing upside 4.6686× NOPAT, reflecting successful restructuring, without raising leverage. The restructuring uplift remains conditional; two deal quotes are not an unlimited addressable supply.

TVK-B2 — Entrans recovery is genuine uncredited optionality. Sellers' reported pre-acquisition earnings and the larger installed manufacturing platform make some recovery economically possible. Test recoveredEarningsFactor1.10 versus 1.00 (10% group recovery, not a forecast of target EBIT), retaining initial factor 1.00 and the three-year recovery mechanism. Sources terravest-entrans-2025, acquisition price/7× EBITDA; terravest-q3-2026-mda, pp.7–8 segment losses and earnout reversal; terravest-fy2025-fs, note 4 pp.18–24. There is no source-derived10% quantum, so this sizes a hypothesis rather than promotes an input. Independent orders/segment results must establish the recovery.

TVK-B3 —17× can survive without perpetual peak growth. A finite diagnostic needs about 14 post-exit years at 7% growth, 13.5% marginal return and 8% required return for 17× cash NOPAT. Proprietary niche equipment, restructuring and cross-selling are the mechanism; energy/heating substitution, governance and larger expensive deals limit it. Test13× to expose duration dependence. Today is a separate judgment. No revenue is fabricated for NOPAT-only funded cohorts.

Isolated shared-engine effects

Saved quote 106.84; market timestamp 2026-11-04T21:00:00.000Z. Fixed valuation date 2026-11-05; model 20a71f6ffc6c; exits remain the original model vintage. These are sensitivities, not joint forecasts or probability revisions. Baseline base IRR 7.94% / 10.16% (5/10 years).

ClaimExact input/path5-year base10-year baseChange, pp (5/10)
TVK-B1cases.base.inputs.acquisitionMultiple12.19%15.62%+4.26 / +5.45
TVK-B2cases.base.inputs.recoveredEarningsFactor11.97%12.86%+4.04 / +2.70
TVK-B3cases.base.inputs.exitMultiple1.07%6.94%-6.87 / -3.22

Bear case

Strongest opposing case

Highland and KBK provide evidence that reasonably priced smaller transactions still exist, while recurring tanks and heating replacement create cash through a trailer downturn. Original2024 source endpoints stay valid as historical calibration.

Bear case

The question is which deal population will receive today's much larger pool of capital. Entrans represents about 80% of recent deal capital and the current cohort's6–8% cash yield is below the 9–10% hurdle. Future base deals instead assume 7.40x mature NOPAT, a13.5% yield, from two smaller issuer-quoted multiples. This is a selection hypothesis, not a measured portfolio-wide result. Highland's rent treatment and future sellers' earnings durability are uncertain. Full committed capital and the trailing acquisition-year cycle point must stay in the denominator. [terravest-fy2025-fs note 4 printed pp.18–24; terravest-entrans-2025; terravest-highland-2023; terravest-kbk-2026; valuation/calculations.json small-deal and cohort bridge.]

Leverage makes waiting costly. Net bank debt isCAD860.3m against 312.2m EBITDA, above the model 2.4x allocation ceiling. In the modeled recession leverage rises above 5x while the engine assumes refinancing rather than issuing equity. Financing at 6% and carrying principal through the March2027/2028 maturities are assumptions, not contractual proof. Measured debt reduction matters more than EBITDA growth purchased with fresh debt. [terravest-q3-2026-mda pp.11–13; terravest-fy2025-fs note 15.1 pp.32–33; research/06-risks.md.]

The issuer's Q3 report itself attributes much of operating-cash growth to payables/customer deposits and notes higher maintenance capital. Deposits arrive with obligations; data-centre orders cannot be treated as permanent replacement demand. Current accounting gains, including contingent-consideration reversals, are already excluded appropriately. Governance allegations are unresolved and cannot be converted into an invented liability, but they reduce conviction in deal access and minority outcomes. [terravest-q3-2026, Business Performance/Cash Available for Distribution; terravest-faguy-authorization-2026-06-19 pp.1–12,18–19; application, not judgment.]

The17x EV/NOPAT exit uses an 8% WACC and 3–5% perpetual growth at 13.5% RONIC. At9–10% capital cost or poorer deals the premium compresses. Do not pair a small-deal return indefinitely with capital supply at large-deal scale.

Contested claims

  • TVK-B1 —Test12.05x future NOPAT purchases, the existing downside's measured adverse/cohort conversion, rather than selecting small-deal7.40x indefinitely.
  • TVK-B2 —Test14x exit versus 17x: still above no-growth12.5x at 8% WACC, and already documented as a sensitivity.
  • TVK-B3 —Test8% bank financing versus 6%, with all operating assumptions held fixed. This is an explicit funding stress, not a quote for the company's current facility.

The Q3 issuer release was reopened; no subsequent court outcome, financing agreement or unpublished financial report was assumed. The missing revenue and cash detail of already-funded cohorts remains a limitation of the current forecast, not a claim that original historical source reproduction failed.

Shared-engine effects

Fixed saved quote CAD106.84; market timestamp 2026-11-04T21:00:00.000Z; valuation date 5 November 2026; fixed original exit calendar. Base before: 7.94% / 10.16% (5/10years). These are one-change sensitivities to the base, except named bundles; existing scenario probabilities are not revised or claimed as validated.

ClaimChange5-year base IRR10-year base IRR5-year effect10-year effect
TVK-B1Future deal multiple 12.0487x5.08%6.51%-2.86pp-3.65pp
TVK-B2Exit14x2.97%7.83%-4.97pp-2.33pp
TVK-B3Bank financing 8% vs 6%7.03%9.38%-0.91pp-0.78pp

Rebuttals

Bull response

5 November 2026. Written after independently frozen openings were exchanged. Every numbered bear claim is addressed below; original bull openings and sensitivities remain unchanged.

  1. Bear12.05× future deals: rebut changing deal populations without matching budget. Base annual purchases~100–150m cannot buy another Entrans; Highland/KBK are more representative in size and issuer-stated prices (terravest-highland-2023, price/multiple; terravest-kbk-2026, price/multiple). The aggregate dominated by Entrans correctly measures what recent capital earned, not necessarily what future small budgets can purchase. Still, two small transactions cannot establish indefinite seller supply; 7.40× is a conditional selection hypothesis and 4.67× successful-restructuring upside. Require new deal-by-deal observations, not aggregate success extrapolation.
  2. Bear8% bank financing: retain stress; no claim current facility repriced. terravest-fy2025-fs, note 15.1 pp32–33 supplies actual loan structure and maturities; model 6% is an underwriting rate. Borrowing capacity falls with earnings, and cash first deleverages before deals. Financing failure or equity issuance can be worse than a higher-rate sensitivity. The next agreement must resolve maturity assumptions.
  3. Bull10% group recovery attacked: concede no quantified estimate. Entrans purchase EBITDA and current trough segment results create an option, not evidence it adds exactly 10% group NOPAT. Keep it a sensitivity until plant orders/prices/utilisation and segment cash validate a bridge. Governance allegations are unresolved, not a fabricated provision. Missing funded-cohort revenue must remain disclosed. Conviction moderate in small-bolt-on mechanism; lower in forecasting consolidated cash through cycle/leverage.

Bear response

5 November 2026, after independent openings were exchanged.

  1. Bull small-deal selection: partly conceded. Planned100–150m annual budgets are a better match for Highland/KBK than another Entrans. Two smaller issuer-quoted multiples justify testing 7.40x NOPAT rather than forcing the Entrans-dominated aggregate onto every future purchase. I concede central 12.05x is not established by mismatched deal populations. The remaining challenge is whether enough such sellers exist at unchanged prices and durable EBITDA (terravest-highland-2023; terravest-kbk-2026; terravest-fy2025-fs, note 4).4.67x requires successful restructuring, not merely purchase at a low EBITDA quote.
  2. Bull10% group recovery: unquantified option conceded by advocate. Current trough segment cash and acquired plants make recovery possible, but neither purchase EBITDA nor a higher equipment installed base establishes precisely 10% extra group NOPAT. Keep it a sensitivity until orders, utilization, prices and margins supply a bridge (terravest-entrans-2025; terravest-q3-2026-mda, pp.7–8). Do not recognize the earnout reversal as recurring cash.
  3. Bear8% funding stress: defended as stress, not current loan quote. The actual debt structure and maturities must determine refinancing exposure; the engine's6% continuation remains an estimate (terravest-fy2025-fs, note 15.1 pp.32–33). Governance allegations, litigation and potential dilution are unresolved, not fabricated quantified claims. The issuer's current cash improvement partly reflects deposits/payables and cannot be promised annually (terravest-q3-2026, Cash Available for Distribution).

No supported central financial-input revision was proved by these arguments. Keep the small-deal mechanism conditional, record the supply and terminal-duration weaknesses, freeze evidence that would distinguish them, and retain lower conviction on consolidated cash through leverage/cycle than on plant economics.

Judgment

Existing estimates receive no presumption merely because they are already in the model. Positive company evidence, the relevant outside view and the capital/funding bridge determine each verdict; neither arbitrary conservatism nor an unsupported favorable sensitivity replaces it. The evidence and reconstruction below explain numerical changes or explicit no-change conclusions claim by claim.

Contested claimVerdictEvidence/locatorReason and model action

Retain existing coarse horizon-specific weights after reassessment: scenarios already represent these adverse/favorable operating mechanisms. Numerical odds are subjective, not verified frequencies; unresolved gaps prevent high conviction. No tuning to return.

Conviction

Low; small-deal economics conditional, refinancing/governance unresolved and revenue-to-owner-cash forecast incomplete. These are forward estimates with surviving attacks, not confirmed outcomes. Neither numerical calibration, a completed checklist nor passing software tests establishes investment skill. Reported facts stay separate from forward judgments, and adverse paths are not worst-case bounds.

What would change the view: Next FY2026 report/debt maturity disclosures: Entrans earnings, maintenance capital and deposits, all-in small deal prices, March2027/2028 refinancing.

Exact inputs, isolated sensitivities, model hashes and same-price/date before/after returns.

Public source library

Primary filings, investor communications, and industry evidence.

primary

TerraVest Q3 FY2026 results ↗

Outlook, portfolio demand and maintenance/cash-generation commentary; numerical table reconciliation retained from the prior review.

Published Aug 13, 2026 · Reviewed Oct 30, 2026
primary

TerraVest FY2025 results ↗

CAD reconciliation and consolidated results table (issuer images inspected) Text: FY2024 comparative adjusted EBITDA 189.599 and sales 911.816; base portfolio sales excluding acquisitions 725.592 vs 717.402 (+1%).

Published Dec 11, 2025 · Reviewed Nov 3, 2026
primary

TerraVest Q3 FY2026 issuer MD&A ↗

Issuer document dated 12 August; pages 5–7 operating performance, 9–10 non-IFRS reconciliations, 11–13 cash, bank debt, shares and options; public filing mirror Page 3: base-portfolio sales excluding acquisitions (nine months 807.382 vs 750.566); pages 7–8: Compressed Gas segment including Entrans.

Published Aug 13, 2026 · Reviewed Nov 1, 2026
primary

TerraVest Q2 FY2026 interim financial statements ↗

Issuer filing mirror: page 2 claims and pension; pages 9–10 KBK purchase and pro forma; page 13 investments; page 16 bank and lease interest; page 17 depreciation/amortization. March balances are carried estimates, not June actuals. Note 5, printed pp.8–11: 2026 KBK/other consideration and acquired cash; finalized 2025 purchase allocations (total consideration 960.516).

Published May 14, 2026 · Reviewed Nov 3, 2026
primary

A. O. Smith Q2 2026 results ↗

Issuer release: North America volume, pricing, boiler growth, input costs and outlook

Published Jul 30, 2026 · Reviewed Oct 27, 2026
primary

Nucor Q3 2026 results ↗

Quarter-on-quarter segment price/volume/cost discussion and Q4 outlook

Published Oct 26, 2026 · Reviewed Oct 28, 2026
primary

Wabash Q3 2026 results ↗

Full issuer release: sales/backlog, adjusted operating loss and cash-flow tables.

Published Oct 29, 2026 · Reviewed Oct 30, 2026
primary

A. O. Smith Q3 2026 results ↗

Full issuer release: North American volume/price/acquisition drivers, segment margins and cash-flow tables.

Published Oct 29, 2026 · Reviewed Oct 31, 2026
primary

TerraVest FY2025 audited financial statements ↗

Note 15.1, printed pp.32–33 (PDF pp.38–39): amended main credit facility, March 2028 expiry and term-loan schedule. Note 4, printed pp.18–24: 2025 and 2024 business-combination consideration, acquired cash, earnout and contribution tables. Cash-flow statement: business-combination cash and sale-of-business proceeds. Note 29, printed pp.55–56: segment results. Statements of financial position, income, equity and cash flows, printed pp.2–6; note 19 shares and options (cash settlement of 100,000 options for 15.693, June 2025); note 21 operating expenses; note 22 financing costs; note 29 segments incl. D&A, assets and capex.

Published Dec 11, 2025 · Reviewed Nov 3, 2026
primary

Trinity Industries Q3 2026 results ↗

Full original release: leasing/manufacturing segment drivers, cash-flow statement, fleet investment and non-GAAP reconciliation.

Published Oct 29, 2026 · Reviewed Nov 1, 2026
primary

TerraVest FY2024 results ↗

Release text: FY2024 sales 911.816 and adjusted EBITDA 189.599; FY2023 comparatives 678.350 and 121.565; base portfolio excluding AEPL, Highland and LV 703.142 (+4%). 3 November 2026 pipeline review: CAD reconciliation image (tableau-2) inspected for FY2024/FY2023 operating cash, working capital, maintenance capex and lease principal.

Published Dec 13, 2024 · Reviewed Nov 3, 2026
primary

TerraVest FY2023 results ↗

Release text: FY2023 sales 678.350, adjusted EBITDA 121.565; FY2022 comparatives 576.704 and 86.669; base portfolio excluding GES, MTC and TSX 483.401 vs 478.336. Tables are images; FY2023 deal consideration not reviewed. 3 November 2026 pipeline review: issuer table images inspected (chart 1 adjusted EBITDA reconciliation, chart 2 CAD reconciliation, chart 3 consolidated results incl. minorities and shares).

Published Dec 13, 2023 · Reviewed Nov 3, 2026
primary

TerraVest FY2022 results ↗

Release text (base-portfolio sales 373.230 vs 296.354; COVID subsidies) and table images 1-ReviewOutlook (adjusted EBITDA reconciliation FY2022/FY2021), 2-CashFlow (CAD reconciliation) and 3-ConsolidatedResults (income statement, minorities, shares).

Published Dec 14, 2022 · Reviewed Nov 3, 2026
secondary

Press and analyst reports of the AMF investigation of TerraVest's Executive Chairman ↗

Public portion: Le Journal de Montréal report of 5 June 2026 summarized (AMF search warrant; alleged tipping before the March 2025 Entrans acquisition; nine connected people, about C$6.8m alleged gains; searches 11 and 13 February 2026; no charges); 30.5% share fall on 5 June. Also Investing.com (https://ca.investing.com/news/stock-market-news/terravest-stock-plunges-on-insider-tipping-allegations-93CH-4678327) and a National Bank Financial note reported by iTiger (Outperform, C$170 target).

Published Jun 25, 2026 · Reviewed Nov 3, 2026
primary

TerraVest management and directors ↗

Biographies: Haw (director 2014, CEO 2017, ex-Clarke VP), Gilbert (CIO since 2013), Cloutier (CFO, joined 2025), segment presidents.

Reviewed Nov 3, 2026
primary

TerraVest acquisition releases, 2022–2026 ↗

MTC (11 Mar 2022), Platinum (Jul 2022), LV (3 Nov 2023, C$25m), Advance (2 Apr 2024), Aureus (Dec 2024), Entrans (17 Mar 2025: US$546m + up to US$46m 12-month earnout, ~7.0× TTM EBITDA; brands Heil, Polar, Kalyn Siebert, Jarco), LBT (4 Apr 2025, EV ~US$16m), Simplex (30 Apr 2025, EV ~US$28m), Tankcon (1 May 2025, EV ~C$27.8m), Colter (15 May 2026), B&R (1 Jun 2026), Jet Peinture (4 Jun 2026), SPV (2 Jul 2026).

Published Jul 2, 2026 · Reviewed Nov 3, 2026
primary claimant pleading; allegations unproven

Faguy & Co: proposed TerraVest class-action authorization motion ↗

Counsel links this original at https://www.faguyco.com/class-actions/terravest?lang=fr . Motion dated 19 June 2026, case 500-06-000040-267. Allegations and parties pp.1–12; relief pp.18–19; undated future presentation p.23; exhibits listed, not attached, pp.24–25. An application for authorization, not a judgment, settlement or quantified award. Current docket and underlying AMF affidavit not retrieved.

Published Jun 19, 2026 · Reviewed Nov 3, 2026
primary government proposal announcement

US DOT announcement of proposed LNG facility safety revisions ↗

Entire announcement read; NPRM addresses LNG facilities/NFPA 59A 2026. Federal Register publication 3 November 2026, document 2026-22396. A proposal; no quantified TerraVest order, margin, compliance cost or direct LPG-tank replacement requirement established. Full 75-page rulemaking not read.

Published Oct 28, 2026 · Reviewed Nov 3, 2026
primary industry statistics

EIA weekly petroleum status summary, week ended 30 October 2026 ↗

Whole summary read: propane/propylene stocks fell 1.6m barrels in the week but were 10% above five-year average; distillate stocks 13% below average. Neither is a direct measurement of tank/trailer orders, pricing or TerraVest profit. Detailed table 6 CSV web decoding failed; no figures inferred from it.

Published Nov 4, 2026 · Reviewed Nov 4, 2026
primary issuer filing (HTML mirror)

TerraVest Q3 2026 issuer financial statements, source transcription ↗

Note5, printed pp9–10: KBK current consideration 123.570m, acquired cash 0.005m, transaction costs 0.834m, contributed9M revenue 43.512m and pro-forma group sales 1,335.743m; note 16 SPV23.375m. Issuer filing content transcribed by mirror, original Q3 PDF not retrieved in this run.

Published Aug 13, 2026 · Reviewed Nov 5, 2026
primary issuer filing

TerraVest FY2024 audited financial statements — Highland acquisition costs ↗

Note4.2 Highland: total acquisition costs 0.522m, of which 0.300m FY2024 and 0.222m FY2023. Current FY2025 comparison repeats only 0.300m; use the source’s full transaction-period amount. Official indexed filing text read; direct viewer access may be unavailable.

Published Dec 13, 2024 · Reviewed Nov 5, 2026
primary public industry statistics

EIA Weekly Natural Gas Storage Report, week ended 30 October 2026 ↗

Release header, regional table and whole summary read. Working gas 3,801 Bcf, net addition77 Bcf, 54 Bcf above five-year average; within historical range. Industry context only, not a TerraVest order, margin or cash forecast. No signed redirect URL retained.

Published Nov 5, 2026 · Reviewed Nov 5, 2026